Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach

Blood

Volumn 126, Issue 6, 2015, Pages 817-824

  Ciciliano, Jordan C ^a,b,c,d   Sakurai, Yumiko ^b,c,d   Myers, David R ^b,c,d   Fay, Meredith E ^b,c,d   Hechler, Beatrice ^e   Meeks, Shannon ^c   Li, Renhao ^c   Dixon, J Brandon ^a,b   Lyon, L Andrew ^d   Gachet, Christian ^e   Lam, Wilbur A ^b,c,d  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b Emory University   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; EPTIFIBATIDE; FERRIC CHLORIDE; HEPARIN; HIRUDIN; VON WILLEBRAND FACTOR; CHLORIDE; FERRIC ION; FIBRINOLYTIC AGENT; PROTEIN AGGREGATE; PROTEIN BINDING;

ARTICLE; BLOOD COMPONENT; COLLOID; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; FERRIC CHLORIDE-INDUCED THROMBOSIS; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MICROFLUIDICS; MOLECULAR MECHANICS; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BIOMECHANICS; CELL AGGREGATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; MICROFLUIDIC ANALYSIS; PATHOLOGY; PRIMARY CELL CULTURE; STATIC ELECTRICITY; THROMBOCYTE; THROMBOCYTE RICH PLASMA; THROMBOSIS;

ASPIRIN; BIOMECHANICAL PHENOMENA; BLOOD PLATELETS; CELL AGGREGATION; CHLORIDES; ERYTHROCYTES; FERRIC COMPOUNDS; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; PLATELET-RICH PLASMA; PRIMARY CELL CULTURE; PROTEIN AGGREGATES; PROTEIN BINDING; STATIC ELECTRICITY; THROMBOSIS;

EID: 84940039424     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-02-628594     Document Type: Article

References (37)

1. Eysholdt K-G. Die experimentelle thrombose und ihre beeinflussung durch heparin und heparinoide. Langenbecks Archiv für Klinische Chirurgie. 1954;277(5):455-470.
2. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res. 1990;60(4):269-280.
3. Farrehi PM, Ozaki CK, Carmeliet P, Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation. 1998;97(10):1002-1008.
4. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA. 1998;95(16):9524-9529.
5. Wang X, Smith PL, Hsu MY, et al. Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice. J Thromb Haemost. 2006;4(9):1982-1988.
6. Westrick RJ, Winn ME, Eitzman DT. Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol. 2007;27(10):2079-2093.
7. Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff DJ, Ruggeri ZM. Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost. 2006;4(9):2014-2021.
8. Massberg S, Gawaz M, Grüner S, et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med. 2003;197(1):41-49.
9. Eckly A, Hechler B, Freund M, et al. Mechanisms underlying FeCl3-induced arterial thrombosis. J Thromb Haemost. 2011;9(4):779-789.
10. Barr JD, Chauhan AK, Schaeffer GV, Hansen JK, Motto DG. Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. Blood. 2013;121(18):3733-3741.
11. Chauhan AK, Kisucka J, Lamb CB, Bergmeier W, Wagner DD. von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins. Blood. 2007;109(6):2424-2429.
12. Owens AP III, Lu Y, Whinna HC, Gachet C, Fay WP, Mackman N. Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model. J Thromb Haemost. 2011;9(9):1862-1863.
13. Kita A, Sakurai Y, Myers DR, et al. Microenvironmental geometry guides platelet adhesion and spreading: a quantitative analysis at the single cell level. PLoS ONE. 2011;6(10):e26437.
14. Myers DR, Sakurai Y, Tran R, et al. Endothelialized microfluidics for studying microvascular interactions in hematologic diseases. J Vis Exp. 2012;(64).
15. Tsai M, Kita A, Leach J, et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest. 2012;122(1):408-418.
16. Blesa MA, Matijević E. Phase transformations of iron oxides, oxohydroxides, and hydrous oxides in aqueous media. Adv Colloid Interface Sci. 1989;29(3-4):173-221.
17. Schäfer AI, Fane AG, Waite TD. Chemical addition prior to membrane processes for natural organic matter (NOM) removal. In: Hahn H, Hoffmann E, Ødegaard H, eds. Chemical Water and Wastewater Treatment V. Berlin, Germany: Springer; 1998:125-137.
18. Flynn CM. Hydrolysis of inorganic iron(III) salts. Chem Rev. 1984;84(1):31-41.
19. Stefánsson A. Iron (III) hydrolysis and solubility at 25 degrees C. Environ Sci Technol. 2007;41(17):6117-6123.
20. Hoeschele JD, Turner JE, England MW. Inorganic concepts relevant to metal binding, activity, and toxicity in a biological system. Sci Total Environ. 1991;109-110:477-492.
21. Duan J, Gregory J. Coagulation by hydrolysing metal salts. Adv Colloid Interface Sci. 2003;100-102:475-502.
22. Matilainen A, Vepsäläinen M, Sillanpää M. Natural organic matter removal by coagulation during drinking water treatment: a review. Adv Colloid Interface Sci. 2010;159(2):189-197.
23. Wolters M, van Hoof RH, Wagenaar A, et al. MRI artifacts in the ferric chloride thrombus animal model: an alternative solution: preventing MRI artifacts after thrombus induction with a non-ferromagnetic Lewis acid. J Thromb Haemost. 2013;11(9):1766-1769.
24. Pusey PN, Van Megen W. Dynamic light scattering by non-ergodic media. Physica A. 1989;157(2):705-741.
25. Bergmeier W, Piffath CL, Goerge T, et al. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA. 2006;103(45):16900-16905.
26. Joglekar MV, Ware J, Xu J, Fitzgerald ME, Gartner TK. Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice. Platelets. 2013;24(3):205-212.
27. Surin WR, Prakash P, Barthwal MK, Dikshit M. Optimization of ferric chloride induced thrombosis model in rats: effect of anti-platelet and anticoagulant drugs. J Pharmacol Toxicol Methods. 2010;61(3):287-291.
28. Bird JE, Giancarli MR, Allegretto N, et al. Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis. Thromb Res. 2008;123(1):146-158.
29. Wang X, Cheng Q, Xu L, et al. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost. 2005;3(4):695-702.
30. Couture L, Richer LP, Cadieux C, Thomson CM, Hossain SM. An optimized method to assess in vivo efficacy of antithrombotic drugs using optical coherence tomography and a modified Doppler flow system. J Pharmacol Toxicol Methods. 2011;64(3):264-268.
31. Schwarz M, Meade G, Stoll P, et al. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ Res. 2006;99(1):25-33.
32. Denis CV, Wagner DD. Platelet adhesion receptors and their ligands in mouse models of thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(4):728-739.
33. Nicolson GL. Anionic sites of human erythrocyte membranes. I. Effects of trypsin, phospholipase C, and pH on the topography of bound positively charged colloidal particles. J Cell Biol. 1973;57(2):373-387.
34. De Bruyn PP, Michelson S, Becker RP. Nonrandom distribution of sialic acid over the cell surface of bristle-coated endocytic vesicles of the sinusoidal endothelium cells. J Cell Biol. 1978;78(2):379-389.
35. Weiss L, Zeigel R. Cell surface negativity and the binding of positively charged particles. J Cell Physiol. 1971;77(2):179-186.
36. Tseng MT, Dozier A, Haribabu B, Graham UM. Transendothelial migration of ferric ion in FeCl3 injured murine common carotid artery. Thromb Res. 2006;118(2):275-280.
37. Ni H, Papalia JM, Degen JL, Wagner DD. Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood. 2003;102(10):3609-3614.